| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $23.3M | +64.9% |
| SG&A Expense | $13.6M | +22.9% |
| Operating Income | -$36.9M | -46.4% |
| Income Tax | $0 | — |
| Net Income | -$36.9M | -49.3% |
| EPS (Basic) | -$3.09 | -44.4% |
| EPS (Diluted) | -$3.09 | -44.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.3M | -58.7% |
| Current Assets | $22.6M | -60.0% |
| Total Assets | $24.0M | -58.5% |
| Current Liabilities | $7.3M | -24.6% |
| Total Liabilities | $7.4M | -24.1% |
| Stockholders' Equity | $16.7M | -65.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.7M | -57.4% |
| Capital Expenditures | $248K | +213.9% |
| Investing Cash Flow | -$248K | -213.9% |
| Financing Cash Flow | $32K | -99.9% |
| Free Cash Flow | -$28.9M | -58.1% |